SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : NanoTechnology

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: RikRichter1/13/2006 9:31:41 AM
  Read Replies (1) of 720
 
NIH Roadmap Nanomedicine Development Centers Informational Meeting

Meeting Date: January 27, 2006
Time: 8AM - 1PM
Place: NIH, Masur Auditorium, Building 10, Bethesda, MD

The NIH Roadmap Nanomedicine Initiative established a national network of Nanomedicine Development Centers (NDC) to stimulate the emerging field of Nanomedicine. The first four NDCs were awarded in fiscal year 2005. This year, a second solicitation will be issued prior to this meeting to add NDCs to the network (RFA-RM-06-007).

The goals of the NIH Nanomedicine initiative are to characterize quantitatively the nanoscale components of the cell and to precisely control and manipulate these molecules and supramolecular assemblies in living cells to improve human health. As a first step, this initiative will define what is needed to precisely control cellular events at the nanoscale. Clearly, the tasks will include data collection, concept and model development, and creation of the physical tools and materials for manipulating the processes and components in living cells.

A second important aspect of this initiative is the recognition that the precise control required to manipulate cellular components will require the understanding and use of engineering principles. To this end, the approach will be informed by the design principles gleaned from the molecular processes and nanomachinery found in living cells. In other words, biological tissues have evolved elegant, intricate pathways, molecular structures, and components at the nanoscale and there is a wealth of information in nature’s design. Once understood, the long-term goal is to exploit these designs to repair intracellular structures at the nanoscale or build new cellular nanomachines for biomedical use.

This meeting will serve as a public forum to:
provide additional information to potential applicants about the solicitation
discuss the NIH vision for the network of NDCs
describe the approaches and goals of the currently funded NDCs

Meeting Information:
Open to all interested potential applicants
Registration required, but there is no registration fee
The meeting will be webcast
Attendance at this meeting, while encouraged, is not a prerequisite for responding to the solicitation.
For additional Information and registration:
nihroadmap.nih.gov
Richard S. Fisher, PhD, Nanomedicine Initiative Project Team Leader
Email: fisherr@mail.nih.gov
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext